Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8211-8220 Newer>

The Motley Fool January 8, 2012 Seth Jayson	AngioDynamics Beats Estimates on Top and Bottom Lines For the quarter ended Nov. 30, AngioDynamics beat expectations on revenues and beat expectations on earnings per share.
Pharmaceutical Executive January 1, 2012 Julian Upton	iPad Apps: Are You Content with your Content? Pharma has become unusually quick to embrace the iPad. But the industry's inherent conservatism means it has some way to go to fully milk the device's potential as a sales tool and as a way to communicate with and educate patients.
Pharmaceutical Executive January 1, 2012 Mason Tenaglia	Letting the Facts Get in the Way An empirical defense of coupons and copay offset programs.
Pharmaceutical Executive January 1, 2012	Compliance: Getting Those Ducks in a Row Pharma must coordinate the efforts of medical, legal, HR, global partners and many other players in the regulatory compliance space to keep itself afloat in choppy seas.
Pharmaceutical Executive January 1, 2012 William Looney	Pharma 2012: Hard Times Before the Harvest 2012 will be a transition year for pharma, one of the most important in its history. The challenge is that many new treatments may not complete the move from 'bench to bedside' in time to plug the yawning revenue gap.
Pharmaceutical Executive January 1, 2012 William Looney	The Well of Engagement We sometimes forget that the business of healthcare is also the source of a huge opportunity: improving the human condition.
Pharmaceutical Executive January 1, 2012 Elys Roberts & Sarah Phillips	The Emergence of the Pro-Patient How can pharma embrace and interact with increasingly informed and demanding patients to bring positive outcomes for all?
Pharmaceutical Executive January 1, 2012 Ben Comer	Top Medical Innovations 2012 A selection of the recent breakthrough technologies showcased at the Cleveland Clinic's Medical Innovations Summit.
Pharmaceutical Executive January 1, 2012	Here's to a Happier New Year? A turbulent year is ahead for European pharma, while EFPIA's Director General begins to rethink its approach to new science.
Pharmaceutical Executive January 1, 2012 Christopher J. Piazza	Essential Questions for Essential Benefits A key consideration under the Affordable Care Act is how states select plans for drug coverage.
<Older 8211-8220 Newer> Return to current articles.